This can still run more if we close above $61 look for next target to $77 then $85
great dip entry here! RSI is telling us this is the perfect dip entry ! long at at 49 with stop loss at 42, price target 80-100 if you are patient with the swing! good risk reward, doesnt get much better than this imo! goodluck as always longs :)
We nailed the reversal on previous post so now we have broken through the 200ma, we are looking at the gap fill as next target $54.80 This is a ripper so be careful , SL in place
ARCT fell a whopping 66% the past 2 days. The catalyst was the inability of its COVID vaccine to produce levels of antibodies comparable to other vaccines in development or already developed. You can check more here: www.investors.com It found support around $41.5 and moved about 12% to the upside to only fall again. It is currently hovering over the $44.3...
Potential reversal opportunity after a harsh selloff as a result of multiple downgrades post vaccine update. Investors looking past the other pipeline projects. Weekly 50ma held Point of Control (POC) held as support. Buyers and traders jumped on the opportunity yesterday. (AS did we) Looking for potential break above the 200ma today, which could ignite a...
Price and volume analysis of Arcturus Therapeutics
Lots of selling pressure due to the recent results release. Looking like a perfect short opportunity.
Breaking out of monster bases, when does it end? My gut is that these things still have a ways to run. Absolutely ugly out there for biotech shorts.
Covid Vaccine Could Be a Drug Industry Game Changer The value of vaccines has never, ever been clearer. With Covid-19 resurgent globally, Pfizer and BioNTechreported Monday that their vaccine looks as if it can cut infection rates by over 90%. Hearts and stocks leapt, especially stocks in pandemic-penned sectors, such as retail, restaurants, and travel. Wednesday,...